Reimbursement and coverage challenges associated with bringing emerging molecular diagnostics into the personalized medicine paradigm

Author： Ridge John R  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.3, Iss.3, 2006-08, pp. : 345-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 3, 2013-03 ,pp. : 252-259

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bringing personalized medicine to the community through public engagement

By Etchegary Holly   Wilson Brenda  

Personalized Medicine, Vol. 10, Iss. 7, 2013-09 ,pp. : 647-659

Future Medicine

Access to resources Recommend Favorite

Personalized Medicine - Trends in Molecular Diagnostics: Exponential Growth Expected in the Next Ten Years†

By Hoggatt Julie  

Molecular Diagnosis & Therapy, Vol. 15, Iss. 1, 2011-02 ,pp. : 53-55

Adis International

Access to resources Recommend Favorite

Regulatory and ethical challenges of personalized medicine

By Torr-Brown Sheryl R  

Personalized Medicine, Vol. 7, Iss. 5, 2010-09 ,pp. : 465-468

Future Medicine

Access to resources Recommend Favorite

Risk-based and diagnostics-linked personalized medicine for cancer

By Srivastava Sudhir   Wagner Paul D  

Personalized Medicine, Vol. 4, Iss. 1, 2007-02 ,pp. : 33-43

Future Medicine

Access to resources Recommend Favorite